CNBX supply chain intelligence for CNBX Pharmaceuticals Inc.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.
Data compiled by Redley Lamar · ChainSifter Intelligence
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| 3I-L-P | 3I-L-P | 92% | On March 10th, 2026, the Company executed a non-convertible Promissory Note with 3i L.P., a Delaware Limited Partnership for the amount of $45,000. |
| INSTITUTIONAL-INVESTOR | INSTITUTIONAL-INVESTOR | 92% | The Institutional Investor agreed to forbear until June 1, 2026 from taking any action against the Company with respect to unpaid amounts owed and to waive certain other defaults under the Note and o… |
| PURISYS | PURISYS | 90% | Additionally, in view of our upcoming submission of a pre-IND meeting request with the FDA, the Company may enter a new agreement with Purisys, a supplier of GMP (Good Manufacturing Practice) grade A… |
| Instrument | Description | Confidence | Evidence |
|---|---|---|---|
| CNBX-DEBT | Debt stack $1.2M | 90% | Market cache reports total debt of $1.2M. |
| CNBX-DEBT-8735 | Xbrl Convertible | 90% | xbrl convertible detail from xbrl 2026-02-28. |
| CNBX-DEBT-8734 | Warrants outstanding: 675123 | 90% | xbrl warrant detail from xbrl 2021-08-31. |